1. Home
  2. HTLD vs ARVN Comparison

HTLD vs ARVN Comparison

Compare HTLD & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartland Express Inc.

HTLD

Heartland Express Inc.

HOLD

Current Price

$12.45

Market Cap

738.1M

Sector

Industrials

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$10.76

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTLD
ARVN
Founded
1978
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.1M
658.2M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
HTLD
ARVN
Price
$12.45
$10.76
Analyst Decision
Hold
Buy
Analyst Count
6
19
Target Price
$11.50
$15.05
AVG Volume (30 Days)
356.8K
651.5K
Earning Date
04-23-2026
05-04-2026
Dividend Yield
0.60%
N/A
EPS Growth
N/A
58.84
EPS
N/A
N/A
Revenue
$805,709,000.00
$262,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.00
$5.90
52 Week High
$13.92
$14.22

Technical Indicators

Market Signals
Indicator
HTLD
ARVN
Relative Strength Index (RSI) 57.76 49.58
Support Level $10.67 $9.02
Resistance Level N/A $12.43
Average True Range (ATR) 0.52 0.51
MACD 0.09 0.04
Stochastic Oscillator 54.35 61.68

Price Performance

Historical Comparison
HTLD
ARVN

About HTLD Heartland Express Inc.

Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: